摘要: Key Adcock stakeholder defends thwarted CFR mergerSeptember 2, 2014 | By Arlene WeintraubIn February, after months of transcontinental controversy driven by shareholders, Chile-based CFR and South Afr ...
Key Adcock stakeholder defends thwarted CFR merger
In February, after months of transcontinental controversy driven by shareholders, Chile-based CFR and South Africa's Adcock Ingram abandoned their planned $1.2 billion merger. A few months later, Abbott ($ABT) swept in and bought CFR for $3 billion. Now, Adcock shareholder Public Investment Corp. (PIC), which owns 25.5% of the company, is forced to defend its opposition to the CFR deal, thanks to poor quarterly results at Adcock. Its case? Opposition to the deal will pay off as investors work to clean up Adcock. And besides, CFR misrepresented its bid, PIC's chief investment officer Dan Matjila told Bloomberg. CFR's bid for Adcock, which is South Africa's largest supplier of hospital products, fell apart after its largest shareholder, Bidvest, bought up 34.5% of its shares and blocked the deal. PIC joined the opposition after detecting that the management of Adcock had misrepresented the company's earnings outlook and its plans for what would happen after the merger, Matjila said in an interview with the news service. "We had been told, give us your assets and in exchange we will give you paper in CFR listed on the Chile stock exchange," Matjila said in the Bloomberg interview. "We'd like to use it, create wealth for ourselves, send it to Chile and then we will probably make you participate when we declare a dividend. We were unhappy with that." Now, Adcock is on its own and clearly facing some challenges. Last week, the company reported flat sales of 3.6 billion rand ($343 million) in the first 9 months of this year and a loss of 1.80 rand (17 cents) per share, compared with a profit of 2.72 rand (25 cents) in the same period a year ago. Bidvest's Kevin Wakeford, who took over the CEO post from Jonathan Louw in February, warned investors during Adcock's earnings call that he's "not expecting any quick fixes," Bloomberg reports. Adcock was deeply entrenched in an expansion plan when the CFR takeover bid arrived last year. Banking on an expanding middle class across Africa, Adcock vowed it would double sales outside its home market to 1 billion rand ($92.5 million) in four years. Bidvest CEO Brian Joffe was asked during his company's earnings call on Monday whether Bidvest would raise its stake in Adcock and take control of the company, according to Bloomberg. His answer was rather circumspect. "I think there have been some strategic errors made," Joffe said. "The medium term prospects for Adcock are there. The only question is to what extent will Bidvest participate in it." |
我们提供专业的服务, 从产品定位、机械的生产制造,我们 实力出众,只因我们更努力
公司生产的生物反应器及各种配套设备,可替代国外同类产品的垄断,并帮助企业节省生产成本,同时提供生产过程中各种技术支持。
我们一如既往地根据用户的需求、市场环境、企业状况等进行综合分析并提供真实可靠的解决方案,迄今为止服务上千家企业。
我们将致力于优质的技术服务确保每个机械设备的安全,用更成熟的方案解决每一个问题,为企业提供一站式服务。